These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 16142874

  • 1. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
    Palm Ø, Bernklev T, Moum B, Gran JT.
    J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
    [Abstract] [Full Text] [Related]

  • 2. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F, López Vivancos J, Malagela JR.
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [Abstract] [Full Text] [Related]

  • 3. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
    Clara I, Lix LM, Walker JR, Graff LA, Miller N, Rogala L, Rawsthorne P, Bernstein CN.
    Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
    [Abstract] [Full Text] [Related]

  • 4. [Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) -- first application and comparison with international investigations].
    Janke KH, Steder-Neukamm U, Bauer M, Raible A, Meisner C, Hoffmann JC, Gregor M, Klump B, Häuser W.
    Gesundheitswesen; 2005 Jul; 67(8-9):656-64. PubMed ID: 16217720
    [Abstract] [Full Text] [Related]

  • 5. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B, Ibsen Study Group.
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [Abstract] [Full Text] [Related]

  • 6. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
    Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM.
    Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
    [Abstract] [Full Text] [Related]

  • 7. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Nørregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group.
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [Abstract] [Full Text] [Related]

  • 8. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ, Zhou Q, Thompson AK.
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [Abstract] [Full Text] [Related]

  • 9. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [Abstract] [Full Text] [Related]

  • 10. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
    Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES.
    Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
    [Abstract] [Full Text] [Related]

  • 11. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV.
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire.
    Casellas F, Alcalá MJ, Prieto L, Miró JR, Malagelada JR.
    Am J Gastroenterol; 2004 Mar; 99(3):457-61. PubMed ID: 15056085
    [Abstract] [Full Text] [Related]

  • 13. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.
    Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F.
    Am J Gastroenterol; 2002 Aug; 97(8):1994-9. PubMed ID: 12190166
    [Abstract] [Full Text] [Related]

  • 14. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J.
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA, De Jesús R, Pérez CM, Iñesta M, Torres D, Morell C, Just E.
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [Abstract] [Full Text] [Related]

  • 16. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity.
    Larsson K, Lööf L, Rönnblom A, Nordin K.
    J Psychosom Res; 2008 Feb; 64(2):139-48. PubMed ID: 18222127
    [Abstract] [Full Text] [Related]

  • 17. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life.
    Casellas F, Vivancos JL, Sampedro M, Malagelada JR.
    Am J Gastroenterol; 2005 Dec; 100(12):2737-42. PubMed ID: 16393228
    [Abstract] [Full Text] [Related]

  • 18. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function.
    Turnbull GK, Vallis TM.
    Am J Gastroenterol; 1995 Sep; 90(9):1450-4. PubMed ID: 7661168
    [Abstract] [Full Text] [Related]

  • 19. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
    Bernstein CN, Nabalamba A.
    Am J Gastroenterol; 2006 Jan; 101(1):110-8. PubMed ID: 16405542
    [Abstract] [Full Text] [Related]

  • 20. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG.
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.